Published in Health Business Week, March 3rd, 2006
Under the terms of the agreement, signed February 2, 2005, Cornell has committed to provide $3 million of funding in the form of secured convertible debentures having a term of 3 years. Less certain fees and expenses $1.5 million was funded at the first closing of the transaction and an additional $1.5 million less certain fees and expenses will be funded immediately prior to the filing by the company with the Securities and Exchange Commission of a registration statement covering...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.